Suchergebnisse - "Bögemann, Martin"

PubPharm (131)

1

Deep and Durable Prostate-specific Antigen Response to Darolutamide with Androgen Deprivation Therapy and Docetaxel, and Association with Clinical Outcomes for Patients with High- or Low-volume Metastatic Hormone-sensitive Prostate Cancer : Analyses of the Randomized Phase 3 ARASENS Study

enthalten in: European urology | 2024

von Saad, F. | Hussain, M. | Tombal, B. | +15

2

Sunitinib for metastatic renal cell carcinoma : Real world data from the STAR-TOR registry and detailed literature review

enthalten in: Urologia internationalis | 2024

von Uhlig, A. | Bergmann, L. | Bögemann, M. | +10

3

Emergencies in cancer immunotherapy

enthalten in: Aktuelle Urologie | 2024

von Handke, A. | Hilser, T. | Bögemann, M. | +2

4

Role of apalutamide in the treatment landscape for patients with advanced prostate cancer : an expert opinion statement of European clinical practice

enthalten in: Irish journal of medical science | 2023

von Bögemann, M. | Facchini, G. | Bauernhofer, T. | +3

5

Efficient Augmented Intelligence Framework for Bladder Lesion Detection

enthalten in: JCO clinical cancer informatics | 2023

von Lee, T. | Laurie, M. | Ge, T. | +8

6

Darolutamide Plus Androgen-Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer by Disease Volume and Risk Subgroups in the Phase III ARASENS Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Hussain, M. | Tombal, B. | Saad, F. | +16

CommentIn: J Clin Oncol. 2023 Jul 10;41(20):3576-3579. - PMID 36947730

7

A Prognostic Risk Score for Prostate Cancer Based on PSMA PET-derived Organ-specific Tumor Volumes

enthalten in: Radiology | 2023

von Seifert, R. | Rasul, S. | Seitzer, K. | +12

CommentIn: Radiology. 2023 May;307(4):e230627. - PMID 37070999

8

Apalutamide in patients with high-risk M0CRPC : data from the pivotal SPARTAN study and initial experience from a compassionate use program

enthalten in: Aktuelle Urologie | 2023

von Hellmis, E. | Schwentner, C. | Mandel, P. | +3

ErratumIn: Aktuelle Urol. 2021 Mar 18;:. - PMID 33738786

9

Apalutamide in patients with high-risk M0CRPC : data from the pivotal SPARTAN study and initial experience from a compassionate use program

enthalten in: Aktuelle Urologie | 2023

von Hellmis, E. | Schwentner, C. | Mandel, P. | +3

ErratumFor: Aktuelle Urol. 2023 Apr;54(2):140-147. - PMID 33621992

10

Co-expression and clinical utility of AR-FL and AR splice variants AR-V3, AR-V7 and AR-V9 in prostate cancer

enthalten in: Biomarker research | 2023

von Wüstmann, N. | Seitzer, K. | Humberg, V. | +10

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[14]